English | Español
Patient Daily | Dec 27, 2025

Neurocrine's valbenazine misses key goals in phase III cerebral palsy trial
Patient Daily | Dec 27, 2025

Novo Nordisk secures FDA approval for first oral obesity treatment
Patient Daily | Dec 27, 2025

Investment banker charged with leaking pharma M&A secrets in insider trading case
Patient Daily | Dec 26, 2025

Advances made in protecting oxygen-sensitive gut bacteria for future therapies
Patient Daily | Dec 26, 2025

Tree nut snacks shown to reduce food cravings among young adults at metabolic risk
Patient Daily | Dec 25, 2025

Cryo-EM study reveals key mechanisms for designing selective NPFFR1 ligands
Patient Daily | Dec 25, 2025

Engineered oncolytic bacteria offer new strategies for targeted cancer therapy
Patient Daily | Dec 25, 2025

Study identifies Fibulin-7 as driver of adipose tissue fibrosis and possible therapy target

Trending
+ Pharmaceuticals
Patient Daily | Mar 9, 2026

Rep. Marshall on 340B expansion: 'If 340B is to continue growing, lawmakers should ensure it truly benefits the underserved'
+ Regulatory
Patient Daily | Mar 9, 2026

Pharmacy owner Kiefer on PBMs: 'Independent pharmacies are being aggressively pushed out of business by the monopolistic practices of PBMs'
+ Pharmaceuticals
Patient Daily | Mar 11, 2026

Alnylam partners with Tenaya Therapeutics on genetic heart disease research
+ Pharmaceuticals
Patient Daily | Mar 11, 2026

Salk scientists find key protein linking GLP-1 drug benefits to pancreatic cell health